Catalyst Funds Management Pty Ltd increased its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 600.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,800 shares of the company's stock after acquiring an additional 2,400 shares during the quarter. Catalyst Funds Management Pty Ltd's holdings in Clorox were worth $455,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Brooklyn Investment Group boosted its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC bought a new stake in shares of Clorox during the 3rd quarter valued at $27,000. Continuum Advisory LLC grew its holdings in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Asset Planning Inc acquired a new stake in shares of Clorox during the 4th quarter worth $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new position in Clorox in the fourth quarter valued at about $36,000. Institutional investors and hedge funds own 78.53% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on CLX. Royal Bank of Canada reiterated a "sector perform" rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. JPMorgan Chase & Co. upped their target price on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. StockNews.com lowered Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Finally, DA Davidson lowered their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Clorox has an average rating of "Hold" and an average price target of $159.62.
Read Our Latest Research Report on CLX
Clorox Trading Up 0.2 %
Shares of NYSE:CLX traded up $0.30 during midday trading on Thursday, hitting $145.46. 1,257,827 shares of the stock were exchanged, compared to its average volume of 1,467,167. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The business's 50-day moving average price is $153.40 and its 200 day moving average price is $159.97. The stock has a market capitalization of $17.92 billion, a price-to-earnings ratio of 39.74, a P/E/G ratio of 2.62 and a beta of 0.45.
Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business earned $2.16 EPS. Analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.35%. Clorox's dividend payout ratio (DPR) is 133.33%.
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.